Anacor Pharmaceuticals

David P. Perry,
Chief Executive Officer
Geoffrey M. Parker,
Chief Financial Officer
Kirk R. Maples, Ph.D.,
Senior Vice President, Program Management
Jacob J. Plattner, Ph.D.,
Senior Vice President, Research
Irwin A. Heyman, Ph.D.,
Senior Vice President, Drug Development
Erik D. Wiberg,
Vice President, Business Development
James R. Marconi,
Vice President, Finance and Controller
Lee T. Zane, M.D.,
Vice President, Clinical Development

Mark Leschly,
Chairman
Paul L. Berns
Anders D. Hove, M.D
Paul H. Klingenstein
David P. Perry
William J. Rieflin
Lucy Shapiro, Ph.D.